Research and analysis

Evaluation of endpoint PCR (EPCR) as a diagnostic test technology for SARS-CoV-2

Technical report summarising results from evaluation of endpoint PCR (EPCR) as a central laboratory based diagnostic test technology for SARS-CoV-2.

• From: Department of Health and Social Care
• Published: 28 January 2021

Documents

Evaluation of endpoint PCR (EPCR) as a central laboratory based diagnostic test technology for SARS-CoV-2

HTML

Details

This is a technical report by the NIHR UK Biocentre Ltd, in partnership with Kings College Hospital NHS Foundation Trust and NHS Test & Trace Scientific Validation and Assurance Group.

It provides evidence verifying the performance of the UltraDx SARS-CoV-2 N1/N2/RP endpoint PCR assay (LGC, Biosearch Technologies).

Published 28 January 2021